Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): statistical and qualitative analysis plan for a randomised controlled feasibility trial

ConclusionThe publication of this analysis plan is designed to aid transparency and to reduce the potential for reporting bias.Trial registrationNIH registry (www.clinicaltrials.gov), registration number NCT03975894 (registered 05/06/19); ISRCTN (www.isrctn.com), registration number ISRCTN52684446 (retrospectively registered 02/08/19).
Source: Trials - Category: Research Source Type: clinical trials